NCT00283595|CompletedPhase 2ResultsDMC
Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
Effect of Supraphysiological rhGH on Bone Metabolism in Patients With Anorexia Nervosa
Loading search results
Sponsor study identifier
interventional
21
1 country
1
Study Start
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2009
Actual (reported)Study Completion
February 2009
Actual (reported)Decreased bone strength is a serious medical problem present in many women with Anorexia Nervosa, or disordered eating. Women with weaker bones are more likely to suffer broken bones than women with normal bone strength. We are investigating whether a hormone that is naturally produced by the human body, called growth hormone, can help strengthen the bones of women with this type of disordered eating.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
January 27, 2006
Actual (reported)January 30, 2006
Actual (reported)February 2009
Actual (reported)February 2009
Actual (reported)October 16, 2012
Actual (reported)Bone Metabolism
Change in the marker of bone formation, N-terminal pro peptide of type 1 procollagen (P1NP) levels, between baseline and 12 weeks
Baseline, 12 weeks
IGF-1 Level
Baseline, 12 Weeks
Treatment with rHGH
Treatment with Placebo
Dosage increased in steps for first four weeks. Self injection qd x 12 weeks
Administered as Arm 1, rHGH active Injection qd x 12 weeks Dosage increase over four weeks
Massachusettes General Hospital
Boston, Massachusetts, 02114, United States
Anne Klibanski, MD
Massachusetts General Hospital
21 participants (actual enrollment reported by the registry).
First Submitted
January 27, 2006
First Posted
January 30, 2006
Study Start
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Growth Hormone Treatment in Children With Phelan McDermid Syndrome
Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
February 2009
Actual (reported)Study Completion
February 2009
Actual (reported)Last Updated
September 2, 2020
Results First Posted
October 16, 2012
Record last verified: 2020-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: